Please login to the form below

Not currently logged in
Email:
Password:

Dr Arndt Schottelius to lead Kymab’s R&D

He takes up the newly-created role of executive vice president of R&D

Kymab Dr Arndt SchotteliusCambridge, UK-based Kymab has appointed Dr Arndt Schottelius to the newly-created position of executive vice president of research and development.

Dr Schottelius will take on responsibility for the human monoclonal antibody specialist's R&D activities, including pre-clinical and clinical developments, from May this year.

He joins from MorphoSys, where he has been chief development officer since 2008, overseeing a portfolio of therapeutic antibody programmes in oncology and immunology.

Previously, Dr Schottelius was medical director of immunology development at Genentech based in San Francisco, US, and held scientific and management positions in immunology research at Berlex Biosciences in California, US and Schering AG in Berlin, Germany.

Dr David Chiswell, chief executive of Kymab, said: “I am delighted to welcome Dr Schottelius to the Kymab team.

“His strong management expertise developed at both MorphoSys AG and Genentech as well as his unique experience and track record in drug development supports our commitment to pursue the opportunities in our R&D programmes following our recent $100m Series C funding.

“Dr Schottelius' appointment validates the current strength and exciting potential of our growing product pipeline.”

3rd February 2017

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
wearable health tech
A cultural shift in clinical research
Research organisations across the board are experimenting with new technologies...

Infographics